Rose Parkinson

Research Associate

20052019

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Rose Parkinson is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 24 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

A phase i trial of the VEGF receptor tyrosine kinase inhibitor pazopanib in combination with the MEK inhibitor trametinib in advanced solid tumors and differentiated thyroid cancers

Kurzrock, R., Ball, D. W., Zahurak, M. L., Nelkin, B. D., Subbiah, V., Ahmed, S., O'Connor, A., Karunsena, E., Parkinson, R., Bishop, J. A., Ha, Y., Sharma, R., Gocke, C., Zinner, R., Rudek-Renaut, M., Sherman, S. I. & Azad, N., Sep 15 2019, In : Clinical Cancer Research. 25, 18, p. 5475-5484 10 p.

Research output: Contribution to journalArticle

  • A phase I trial of a guadecitabine (SGI-110) and irinotecan in metastatic colorectal cancer patients previously exposed to irinotecan

    Lee, V., Wang, J., Zahurak, M., Gootjes, E., Verheul, H. M., Parkinson, R., Kerner, Z., Sharma, A., Rosner, G., De Jesus-Acosta, A., Laheru, D., Le, D., Oganesian, A., Lilly, E., Brown, T., Jones, P., Baylin, S. B., Ahuja, N. & Azad, N., Dec 15 2018, In : Clinical Cancer Research. 24, 24, p. 6160-6167 8 p.

    Research output: Contribution to journalArticle

  • Erratum: The oral VEGF receptor tyrosine kinase inhibitor pazopanib in combination with the MEK inhibitor trametinib in advanced cholangiocarcinoma (British journal of cancer (2017) 116 11 (1402-1407))

    Shroff, R. T., Yarchoan, M., O'Connor, A., Gallagher, D., Zahurak, M. L., Rosner, G., Ohaji, C., Sartorius-Mergenthaler, S., Parkinson, R., Subbiah, V., Zinner, R. & Azad, N. S., Jan 1 2018, In : British journal of cancer. 118, 2, p. e2

    Research output: Contribution to journalComment/debate

    Open Access

    Systematic review of intravenous ascorbate in cancer clinical trials

    Nauman, G., Gray, J. C., Parkinson, R., Levine, M. & Paller, C., Jul 12 2018, In : Antioxidants. 7, 7, 89.

    Research output: Contribution to journalReview article

  • Egr3 induces a Th17 response by promoting the development of γδ T cells

    Parkinson, R. M., Collins, S. L., Horton, M. R. & Powell, J. D., Jan 24 2014, In : PloS one. 9, 1, e87265.

    Research output: Contribution to journalArticle